BCAL Diagnostics

BCAL Diagnostics EBIT per Share

The EBIT per Share of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is -0.02 AUD. In the previous year, EBIT per Share was -0.03 AUD — a change of -21.66% (higher).

EBIT per Share

-0.02AUD

YoY

-21.66%

Last updated:

EBIT per Share of BCAL Diagnostics is 2025 -0.02 AUD. EBIT per Share of BCAL Diagnostics was 2024 -0.03 AUD. It decreases by -21.66% higher compared to the previous year.

The BCAL Diagnostics EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-0.00 AUD
Jan 1, 2020
-0.00 AUD
Jan 1, 2021
-0.00 AUD
Jan 1, 2022
-0.02 AUD
Jan 1, 2023
-0.02 AUD
Jan 1, 2024
-0.03 AUD
Jan 1, 2025
-0.02 AUD
Jan 1, 2026 (e)
-0.03 AUD
The BCAL Diagnostics EBIT per Share history
YEAREBIT per ShareYoY
est-0.03AUD+75.52%
-0.02AUD-21.66%
-0.03AUD+5.66%
-0.02AUD+50.83%
-0.02AUD+248.08%
-0.00AUD+34.19%
-0.00AUD+63.36%
-0.00AUD-7.88%
-0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

EBIT per Share of BCAL Diagnostics is -0.02 AUD in 2025.

EBIT per Share of BCAL Diagnostics changed from -0.03 AUD to -0.02 AUD, representing a -21.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — BCAL Diagnostics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BCAL Diagnostics